Quick Summary

Senna (Senna alexandrina) is a medicinal plant traditionally used primarily as a laxative. It contains active compounds such as anthraquinones, which have demonstrated laxative effects. Clinical evidence supports its use in treating constipation. Limited human clinical data exist on other therapeutic uses. There is some evidence suggesting potential hepatotoxicity related to alternative medicine use of senna-containing products. Safety and efficacy data in pregnancy and breastfeeding are insufficient. Further high-quality controlled clinical studies are needed.

What is it

Senna is a flowering plant native to parts of Africa and the Middle East, widely used in traditional medicine systems. Its leaves and pods contain compounds that stimulate bowel movements, making it a common ingredient in herbal laxatives.

Traditional Uses

  • Primarily used as a natural laxative for constipation relief.
  • Occasionally included in herbal formulations for digestive support and bowel regulation.

Active Compounds

The key active constituents in Senna are anthraquinone glycosides (e.g., sennosides), which are responsible for its laxative effects by stimulating intestinal motility and increasing fluid secretion in the colon.

Potential Benefits with Evidence Levels

  • Laxative effect for constipation
    Evidence level: Human clinical evidence from randomized controlled trials.
    Details: A randomized crossover placebo-controlled trial demonstrated a significant reduction in colonic transit time and increased bowel movements using a phytotherapic compound containing Senna alexandrina along with other herbs (Picon et al., 2010; PMID 20433751). Another trial found efficacy for pediatric functional constipation using a related species, Cassia fistula (Mozaffarpur et al., 2012; PMID 23351337).
  • Treatment of irritable bowel syndrome with diarrhea (IBS-D)
    Evidence level: Preclinical animal study.
    Details: A mouse model study using Senna alexandrina in a traditional Chinese medicine formula showed improvements in colonic inflammation and modulation of intestinal microbiota, suggesting possible benefits in IBS-D; no human clinical trials reported (Yu et al., 2025; PMID 41114050).

Side Effects

  • Electrolyte imbalance (e.g., hypokalemia) especially with prolonged use.
  • Gastrointestinal discomfort such as cramping and diarrhea.
  • Potential hepatotoxicity with herbal products containing senna or anthraquinones, particularly with long-term or high-dose use.

Drug Interactions

  • Potential interactions with other laxatives and medications affecting electrolytes or renal function.
  • Limited clinical data on cytochrome P450-mediated herb-drug interactions specific to senna; caution is advised especially in cases of polypharmacy.
  • No high-quality evidence currently exists for severe clinical herb-drug interactions, partly due to limited data and poor reporting (Posadzki et al., 2013; PMID 22670731; Fasinu et al., 2012; PMID 22557968).

Who Should Avoid It

  • Individuals with known hypersensitivity to senna or related compounds.
  • People with intestinal obstruction, inflammatory bowel disease, appendicitis, or other acute abdominal conditions requiring medical supervision.
  • Pregnant and breastfeeding women, due to limited safety data; use should be avoided or carefully monitored.

Evidence Limitations

  • Most clinical studies involve senna as part of polyherbal mixtures, limiting attribution of effects to senna alone.
  • Human clinical trials are primarily limited to constipation; data on other indications are mainly preclinical or observational.
  • Clinical evidence quality ranges from low to moderate due to small sample sizes and methodological limitations.
  • Long-term safety data and data in special populations (pregnant women, children, elderly) remain insufficient.
  • Lack of product standardization leads to variability in study results and clinical effects.

References

  • Picon PD, Picon RV, Costa AF, et al. Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation. BMC Complement Altern Med. 2010;10:17. PMID: 20433751.
  • Mozaffarpur SA, Naseri M, Esmaeilidooki MR, et al. The effect of cassia fistula emulsion on pediatric functional constipation in comparison with mineral oil: a randomized, clinical trial. DARU. 2012;20:83. PMID: 23351337.
  • Yu D, Tian Q, Shen J, et al. Deciphering the microbiological mechanism of Tongxie Yaofang in treating IBS-D: a multimodal mechanistic study in mice integrating network pharmacology, computational simulation, and 16S rRNA sequencing. Front Evid Based Med. 2025;10:10725. PMID: 41114050.
  • Philips CA, Theruvath AH, Ravindran R, et al. A comprehensive review on the hepatotoxicity of herbs used in the Indian (Ayush) systems of alternative medicine. Medicine. 2024;103(10):e37903. PMID: 38640296.
  • Budzynska K, Gardner ZE, Dugoua JJ, Low Dog T, Gardiner P. Systematic review of breastfeeding and herbs. Breastfeed Med. 2012;7(6):489-503. PMID: 22686865.
  • Holst L, Havnen GC, Nordeng H. Echinacea and elderberry—should they be used against upper respiratory tract infections during pregnancy? Front Pharmacol. 2014;5:31. PMID: 24624087.
  • Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2013;75(3):603-618. PMID: 22670731.
  • Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol. 2012;3:69. PMID: 22557968.

Last Reviewed

June 2024

Informational Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Please consult a healthcare professional before using Senna or any other herbal supplements, especially if you have underlying health conditions or are taking medications.